Tirzepatide storage and shelf life: the real rules

Last updated 2026-07-27

How should you store tirzepatide before you open it?

Unopened tirzepatide, whether it's a Mounjaro or Zepbound single-dose pen, a vial, or a compounded preparation, needs to live in the refrigerator at 2°C to 8°C (36°F to 46°F) until the expiration date printed on the carton ^[1][2]. That's a standard pharmaceutical cold chain requirement, not a suggestion. Don't store it in the door of the fridge, where temperature swings are worst every time someone opens it. A middle shelf, away from the back wall (which can freeze), is the safer spot. Both the Mounjaro and Zepbound prescribing information state the product should be kept refrigerated "until the expiration date" and explicitly warn against freezing ^[1][2]. If a pen or vial has frozen, even once, don't use it. Ice crystal formation can degrade the peptide structure, and there's no reliable way to tell by looking at it whether that's happened. If you're just getting your dosing schedule sorted, it helps to read up on Tirz Rx dosage before you even open the box, since how you store and handle the drug ties directly into how you'll be drawing up or dialing each dose.

Can tirzepatide be stored at room temperature?

Yes, but only for a limited stretch and only below 30°C (86°F). The FDA label for both Mounjaro and Zepbound pens states that if refrigeration isn't available, the product can be stored at room temperature, not exceeding 30°C, for up to 21 days ^[1][2]. That 21-day room-temperature allowance is meant for real-world situations: travel, a power outage, a fridge that's not accessible. It's not a green light to just leave pens on the counter as a matter of routine. Once that 21-day room-temperature clock starts (or once the pen is first used), you don't get to put it back in the fridge and reset a fresh 21 days. The clock runs once, continuously, from whichever point (opening or first room-temp exposure) starts it. For compounded tirzepatide from a compounding pharmacy, the rules are set by that specific pharmacy's beyond-use date (BUD), not the FDA label, because compounded drugs aren't FDA-approved products with FDA-reviewed stability data. USP General Chapter <795> governs how compounding pharmacies assign BUDs for non-sterile and sterile preparations, and those dates are typically far shorter and more conservative than what's printed on a branded drug label ^[3]. Always follow the BUD on your specific vial's label rather than assuming Zepbound's 21-day rule applies.

How long does an opened or in-use tirzepatide pen or vial last?

For Mounjaro and Zepbound single-dose pens, once first used, the pen should be discarded after 21 days even if stored in the refrigerator afterward, per Lilly's prescribing information ^[1][2]. These are single-dose pens (KwikPens), so in practice most people use the entire pen in one injection anyway. Multi-dose considerations mostly apply to compounded vials. For compounded tirzepatide vials, once reconstituted (mixed from lyophilized powder with bacteriostatic water or similar), shelf life depends heavily on the compounding pharmacy's own stability testing and BUD assignment. Reported ranges in practice commonly run 14 to 28 days when refrigerated, though this varies by pharmacy, reconstitution diluent, and concentration. There's no FDA-approved reconstituted-vial product to point to for an authoritative number here, since Mounjaro and Zepbound ship pre-mixed in solution, not as powder. That's an important, honest gap: nobody has a single definitive number for compounded vial life, because it isn't standardized across compounders the way an FDA-approved drug's stability data is. If you're reconstituting from powder, the mixing step itself matters for both safety and shelf life; using too much force, letting the vial sit warm during mixing, or using the wrong diluent can shorten how long the reconstituted solution stays stable. Full technique is covered in how to reconstitute Tirz Rx. | Product type | Unopened storage | Unopened shelf life | Opened/in-use storage | Opened/in-use limit |

What temperature actually ruins tirzepatide?

Two temperature extremes matter: freezing and heat above 30°C (86°F). Freezing is the more absolute failure. Lilly's labeling explicitly instructs patients not to freeze Mounjaro or Zepbound, and to discard the pen if it has been frozen ^[1][2]. Peptide drugs like tirzepatide can suffer physical degradation (aggregation, structural changes) when ice crystals form during freezing, and that damage isn't reversible by thawing. Heat is more forgiving up to a point but still has hard limits. The room-temperature allowance tops out at 30°C (86°F). A car dashboard in summer, a gym bag left in direct sun, or a mail parcel sitting on a hot porch can all exceed that threshold quickly, sometimes within an hour. If tirzepatide has been exposed to temperatures above 30°C for an extended period, or you're not sure how hot it got or for how long, the safer call is to not use it and get a replacement. Light exposure is a smaller factor but still worth managing: keep pens and vials in their original carton when not in active use, since the outer packaging is designed to block light that can also degrade the solution over time.

How do you know if tirzepatide has gone bad?

Visual inspection catches some problems but not all of them. Before every injection, look at the solution: it should be clear and colorless to slightly yellow, per Lilly's product information for both Mounjaro and Zepbound ^[1][2]. Don't use it if you see particles floating in it, if it looks cloudy, or if the color has changed noticeably (visibly yellow, brown, or discolored beyond the normal slight-yellow tint). The problem is that a lot of degradation from time-temperature abuse doesn't show up visually at all. A pen that's been left out past its 21-day window, or briefly frozen, can still look perfectly clear. That's exactly why the labeled time and temperature limits matter more than "does it look okay," and why tracking dates (when you first opened it, whether it's ever been left in a hot car) matters as much as looking at the vial. If you're ever unsure whether a pen or vial is still good, the safe default is to not inject it and to talk to the prescribing provider or pharmacy about a replacement, rather than guessing.

Can you travel with tirzepatide, and how do you keep it cold?

Yes, and the 21-day room-temperature allowance (below 30°C) built into the Mounjaro and Zepbound labels ^[1][2] is specifically what makes short trips workable without a mini-fridge. For longer trips, an insulated travel case with an ice pack or gel pack keeps the pen in the 2-8°C range, which is the safer bet if you're traveling more than a few days or heading somewhere hot. Don't pack it in checked luggage, where cargo holds can get cold enough to risk freezing and where temperature control is out of your hands entirely. Carry it on, in an insulated bag, through airport security; TSA allows medications and the diluents/supplies that go with them in carry-on bags. If you're flying to a hot climate and can't guarantee refrigeration on arrival, plan around the 21-day room-temperature ceiling rather than assuming you'll find a fridge. Once that window closes, the dose needs to be discarded regardless of how it looks. For day-to-day handling once you're set up at home, pairing correct storage with Tirz Rx how to inject and picking the right rotation of Tirz Rx injection sites rounds out the practical side of using the drug correctly, more than storing it correctly.

Does compounded tirzepatide have the same shelf life as Mounjaro or Zepbound?

No, and this is one of the more important distinctions to understand. Mounjaro and Zepbound are FDA-approved products manufactured by Eli Lilly, each with stability data reviewed by the FDA that supports their specific expiration dates and the 21-day in-use window ^[1][2]. Compounded tirzepatide is not FDA-approved; it's prepared by a compounding pharmacy, typically from bulk tirzepatide, under a prescription for an individual patient. Because compounded preparations aren't reviewed by the FDA for stability, their shelf life is governed by the compounding pharmacy's own beyond-use date, assigned under USP <795> and USP <797> standards for non-sterile and sterile compounding respectively ^[3]. Reputable compounding pharmacies do stability testing to support their assigned BUDs, but that testing and the resulting dates vary from pharmacy to pharmacy. There isn't one universal number for how long a compounded vial is good for. The FDA has also been explicit that it doesn't review compounded drugs for safety, effectiveness, or quality before they reach patients, which is a structural difference worth understanding regardless of which product you use ^[4]. This doesn't mean compounded tirzepatide is unsafe by default, but it does mean the storage and shelf-life answer for a compounded vial always comes back to "check the label from the specific pharmacy that compounded it," not to Zepbound's FDA label.

What's the difference in storage rules across the different GLP-1/GIP drugs?

Most GLP-1 and GIP-based injectables share the same broad cold-chain logic: refrigerate until use, protect from freezing, allow a limited room-temperature window. But the specific numbers differ by drug and manufacturer. | Drug | Manufacturer | Unopened storage | Room-temp allowance (in-use) |

What if you accidentally freeze or overheat a dose?

Discard it. Both the Mounjaro and Zepbound labels are unambiguous that a frozen pen should not be used ^[1][2], and there's no reliable at-home test to confirm whether freezing has caused enough protein/peptide degradation to matter. The safe assumption is that any freezing event means the dose is compromised. For overheating, the calculation is a little softer because the label already bakes in a 21-day allowance up to 30°C. Brief exposure slightly above 30°C (a hot car for twenty minutes, say) is a genuine gray area that the label doesn't explicitly address. If you know or suspect a pen sat somewhere significantly hotter than 30°C for more than a short period, the responsible move is to treat it as compromised and get a replacement rather than risk injecting a degraded dose that may be less effective or, in theory, could contain altered protein structures. This is also a good moment to mention that dose accuracy and storage go hand in hand. A pen that's been mishandled thermally doesn't just risk lower potency; it also removes any confidence in dose consistency, which matters if you're actively titrating. Anyone still working out their titration schedule might find it useful to cross-reference a Tirz Rx dosage calculator alongside storage habits, since both affect how predictably the dose lands week to week.

Where does tirzepatide's efficacy and safety data actually come from?

Tirzepatide's approval rests on two major trial programs. The SURPASS program (SURPASS-1 through SURPASS-5 and beyond) studied tirzepatide for type 2 diabetes, comparing it against placebo, insulin, and other GLP-1 agonists; SURPASS-2, for example, compared tirzepatide against semaglutide 1 mg in adults with type 2 diabetes (NCT03987919) . The SURMOUNT program (SURMOUNT-1 through SURMOUNT-4) studied tirzepatide for chronic weight management; SURMOUNT-1 enrolled adults with obesity or overweight with at least one weight-related condition and ran for 72 weeks (NCT04184622) . In SURMOUNT-1, participants on the highest dose (15 mg) lost an average of 20.9% of body weight over 72 weeks compared with 3.1% on placebo, according to the trial results published in the New England Journal of Medicine . That level of weight loss is a big part of why tirzepatide (as Zepbound) got FDA approval for chronic weight management in adults with obesity or overweight with a weight-related condition. None of that trial data addresses storage directly; storage and shelf life come from the manufacturer's separately submitted stability studies, which sit alongside but distinct from the efficacy trials in the FDA approval package. It's worth knowing the trials exist and what they showed, but they're not the source for the temperature numbers discussed above; the product labeling is ^[1][2].

What are the real side effects and warnings to know alongside storage?

Storage mistakes aren't the main safety concern with tirzepatide; the drug's own side-effect and contraindication profile matters more day to day. The most common adverse effects across the SURPASS and SURMOUNT trials are gastrointestinal: nausea, diarrhea, vomiting, constipation, and decreased appetite, generally most pronounced during dose escalation ^[1][2]. Both Mounjaro and Zepbound carry a boxed warning about the risk of thyroid C-cell tumors, based on findings in rodent studies; the drug is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) ^[1][2]. This is a labeled boxed warning, not a rare footnote, and it rules the drug out entirely for people in those risk categories. Other labeled risks include acute pancreatitis (discontinue if suspected), gallbladder problems (including cholelithiasis and cholecystitis), acute kidney injury (often secondary to GI-related dehydration), hypoglycemia risk when combined with insulin or sulfonylureas, and diabetic retinopathy complications in patients with type 2 diabetes ^[1][2]. None of this is storage-related, but anyone thinking carefully about how to handle and use the drug safely should be reading the full labeled warnings, more than the temperature chart. A properly provider-reviewed prescription means these contraindications get screened for before you ever have a vial to store.

What should you actually do with expired or leftover tirzepatide?

Don't use it, and don't just toss it in the household trash or flush it. Needles and pens are sharps waste and need proper disposal through a sharps container or a community take-back program; check local pharmacy or municipal household hazardous waste guidance for drop-off locations. Expired product, even if it looks fine, has moved past the point where the manufacturer's (or compounder's) stability data can vouch for its potency or safety. Potency can decline gradually past the expiration date rather than failing all at once, so an expired pen might still "work" a little, which is exactly the problem: you'd be dosing something with unknown, unverifiable strength. If you've got leftover doses because a prescription changed or a cycle ended, that's also a good moment to think about what comes next; the question of stopping, pausing, or restarting is covered in Tirz Rx cycle length. For a first prescription or a refill, working with a provider-reviewed telehealth route (Tirz Rx connects patients to licensed prescribers and the fulfilling pharmacy handles compounding and dispensing under that prescription) keeps the whole chain, from prescription to storage instructions on the label, consistent and traceable back to a real clinician and licensed pharmacy.

Frequently asked questions

Does tirzepatide need to be refrigerated the whole time?

Unopened, yes: keep it at 2-8°C until the expiration date on the box. Once opened or in active use, both Mounjaro and Zepbound can tolerate up to 21 days at room temperature below 30°C, per FDA labeling. After that window, whether refrigerated again or not, it should be discarded.

Can tirzepatide be left out overnight?

One night at normal room temperature (below 30°C/86°F) generally falls well within the labeled 21-day allowance for Mounjaro and Zepbound pens, so it should be fine. Just don't let it sit somewhere hot, like near a radiator or in direct sun, and get it back in the fridge or track the 21-day clock from that point.

What happens if tirzepatide freezes?

Discard it. Lilly's prescribing information for both Mounjaro and Zepbound explicitly states the product should not be used if it has been frozen. There's no reliable home test for this kind of degradation, so the label's instruction is to treat any frozen pen as unusable, regardless of appearance.

How long does a Mounjaro or Zepbound pen last once opened?

Up to 21 days, stored either in the refrigerator or at room temperature below 30°C (86°F), according to Lilly's FDA-approved labeling for both products. Since these are single-dose pens, most people use the full pen in one injection anyway, so this window matters mainly for how long you can hold an opened box before using it.

Is compounded tirzepatide's shelf life the same as Zepbound's?

Not necessarily. Compounded tirzepatide isn't FDA-approved, so its shelf life comes from the specific compounding pharmacy's beyond-use date (BUD), assigned under USP <795>/<797> standards, not from Lilly's label. Reported ranges for reconstituted compounded vials commonly run 14-28 days refrigerated, but always defer to the date on your specific vial.

Can you travel by plane with tirzepatide?

Yes. Keep it in carry-on luggage (not checked, where cargo holds risk freezing), ideally in an insulated bag with a cold pack for trips longer than a few days. The label's 21-day room-temperature allowance below 30°C covers most short trips without refrigeration.

How can you tell if tirzepatide has gone bad?

Check that the solution is clear and colorless to slightly yellow; discard it if it's cloudy, discolored, or has visible particles, per FDA labeling for Mounjaro and Zepbound. But visual inspection doesn't catch everything: time-and-temperature abuse (like exceeding the 21-day room-temp window or a freezing event) can degrade the drug without any visible change.

What temperature is too hot for storing tirzepatide?

Above 30°C (86°F) is outside the labeled safe range for Mounjaro and Zepbound once out of the refrigerator. Hot cars, direct sunlight, and mail left on a hot porch can all exceed that threshold. If you're unsure how hot a dose got or for how long, treat it as compromised.

Does tirzepatide expire, and where's the expiration date?

Yes. The expiration date is printed on the carton and pen, and applies as long as the product has been continuously refrigerated at 2-8°C and never opened. Once opened, the shorter 21-day in-use limit takes over regardless of the printed expiration date, whichever comes first.

Can you refrigerate tirzepatide again after it's been at room temperature?

You can, but it doesn't reset the clock. The 21-day in-use limit for Mounjaro and Zepbound runs continuously from when the pen was first used or first taken out of continuous refrigeration, whether it spends that time in the fridge, at room temperature, or a mix of both.

How should you dispose of expired or unused tirzepatide pens?

Use a sharps container for the needle/pen components and check local pharmacy or municipal take-back programs for medication disposal; don't flush it or throw it in regular household trash. Expired doses shouldn't be injected even if they look normal, since potency can decline gradually past the labeled expiration or in-use window.

Is it safe to use tirzepatide past its 21-day in-use window if it still looks clear?

No. The 21-day limit for Mounjaro and Zepbound is based on the manufacturer's stability data, not visual appearance. A solution can look perfectly clear while potency has already declined past that window, so the safer choice is to discard it and use a fresh pen rather than guess.

Sources

1. FDA, Mounjaro (tirzepatide) prescribing information: Storage requirements (2-8°C refrigeration, 21-day room-temp allowance below 30°C, no freezing), boxed warning on thyroid C-cell tumors, and common GI adverse effects
2. FDA, Zepbound (tirzepatide) prescribing information: Storage requirements (2-8°C refrigeration, 21-day room-temp allowance below 30°C, no freezing), boxed warning on thyroid C-cell tumors, and appearance/inspection guidance
3. USP, General Chapter <795> Pharmaceutical Compounding - Nonsterile Preparations: Beyond-use dates for compounded preparations are assigned by the compounding pharmacy based on USP standards, distinct from FDA-approved product labeling
4. FDA, Wegovy (semaglutide) prescribing information: Wegovy in-use room-temperature allowance of up to 28 days below 30°C
5. ClinicalTrials.gov, SURPASS-2 trial record: SURPASS-2 compared tirzepatide against semaglutide 1 mg in adults with type 2 diabetes
6. ClinicalTrials.gov, SURMOUNT-1 trial record and NEJM results: SURMOUNT-1 enrolled adults with obesity/overweight and a weight-related condition, running 72 weeks, showing 20.9% average weight loss at the 15 mg dose versus 3.1% for placebo